SEATTLE, May 31, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced the initiation of the planned pharmacokinetic (PK) substudy in its Phase 3 clinical program evaluating

MONROVIA, Calif., May 29, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it

SEE FOR YOURSELF is a one-of-its-kind book which provides people looking to improve their vision with information on the most up-to-date vision correction techniques so they are well informed

MONROVIA, Calif., May 21, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that

MONROVIA, Calif., May 16, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced